NCT07517705: MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma
- State
- Not started
- Phase
- Phase 2
- People
- 50 planned
- Started
- 12 Dec 2026
- Primary completion
- 12 Feb 2031
- Arms
- Arm- A: MRD-Detectable with Protocol-Directed LDRT
- Results
- None posted
- 8 Apr 2026: Trial registered